Position in VSTM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,235,945
-$5,932,804 QoQ
Shares Held
2,308,669
-1.9% QoQ
Ownership
2.63%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VSTM Over Time
Shares Held
Position Value (USD)
Derivatives in VSTM
reported options exposure · as of Mar 31, 2026CallValue
$279,310
CallShares
52,700
PutValue
$78,970
PutShares
14,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITADEL ADVISORS LLC holds $5,784,241,435 across 374 Biotechnology names. VSTM ranks #86 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
2,182,571 | $356,894,009 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
1,032,298 | $306,561,536 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
4,512,634 | $254,918,694 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,259,444 | $238,097,887 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
453,843 | $237,573,195 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
3,173,940 | $235,696,783 | |
| 7 | TERN |
Terns Pharmaceuticals, Inc.
|
3,218,810 | $169,695,662 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
1,551,900 | $163,570,260 |
All Filings in VSTM
Export CSV
34 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $78,970 | 14,900 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $279,310 | 52,700 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $12,235,945 | 2,308,669 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,168,749 | 2,353,465 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $260,936 | 33,800 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $325,012 | 42,100 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $344,370 | 39,000 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $519,204 | 58,800 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $1,632,136 | 184,840 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $152,720 | 36,800 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $75,945 | 18,300 | Put | Defined | 2025-08-14 | |
| 2025-03-31 | $122,409 | 20,300 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $82,611 | 13,700 | Call | Defined | 2025-05-15 | |
| 2024-12-31 | $1,766,428 | 341,669 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $152,515 | 29,500 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $49,115 | 9,500 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $14,950 | 5,000 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $37,674 | 12,600 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $8,757 | 2,929 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $13,708 | 4,600 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $48,276 | 16,200 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $90,592 | 30,400 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $469,734 | 39,808 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $141,600 | 12,000 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $33,040 | 2,800 | Put | Defined | 2024-05-15 | |
| 2023-12-31 | $4,690,520 | 576,231 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $26,862 | 3,300 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $14,652 | 1,800 | Put | Defined | 2024-02-14 | |
| 2023-09-30 | $36,812 | 4,528 | Call | Defined | 2023-11-14 | |
| 2023-09-30 | $27,642 | 3,400 | Put | Defined | 2023-11-14 | |
| 2023-09-30 | $7,266,472 | 893,785 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $35,354 | 4,752 | Call | Defined | 2023-08-14 | |
| 2023-06-30 | $6,915,033 | 929,440 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $29,819 | 4,008 | Put | Defined | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||